Academic articles published by scientists affiliated with the Danish Dementia Research Centre in 2010 are presented below:
- Bech S, Petersen T, Nørremølle A, Gjedde A, Ehlers L, Eiberg H,
Hjermind LE, Hasholt L, Lundorf E & Nielsen JE. Huntington's
disease-like and ataxia syndromes: identification of a family with
a de novo SCA17/TBP mutation. Parkinsonism Relat Disord 2010
Jan;16(1):12-15.
- Bhattacharya S, Vogel A, Hansen ML, Waldorff FB & Waldemar
G. Generic and disease-specific measures of quality of life in
patients with mild Alzheimer's disease. Dement Geriatr Cogn Disord
2010;30(4):327-33.
- Cummings J, Jones R, Wilkinson D, Lopez O, Gauthier S, Waldemar
G, Zhang R, Xu Y, Sun Y, Richardson S & Mackell J. Effect of
donepezil on cognition in severe Alzheimer's disease: a pooled data
analysis. J Alzheimers Dis 2010;21(3):843-51.
- Gauthier S, Lopez OL, Waldemar G, Jones RW, Cummings J, Zhang
R, Schindler R & Schwam E. Effects of donepezil on activities
of daily living: integrated analysis of patient data from studies
in mild, moderate and severe Alzheimer's disease. Int Psychogeriatr
2010 Sep;22(6):973-83.
- Inzitari D, Poggesi A, Pracucci G, Barkhof F, Chabriat H, Erkinjuntti T, Fazekas F, Hennerici M, Langhorne P, O'Brien JT, Scheltens P, Schmidt R, Verdelho A, Visser M, Wahlund LO, Waldemar G, Wallin A & Pantoni L. Risk of Functional Decline by Grade of Age-Related White Matter Changes: Sixth Year Follow-Up of the LADIS (Leukoaraiosis And Dissability in Elderly) Study Cohort. Neurology 2010;75(4):379-80.
- Josefsen K, Nielsen SM, Campos A, Seifert T, Hasholt L, Nielsen
JE, Nørremølle A., Skotte NH, Secher, NH & Quistorff B. Reduced
gluconeogenesis and lactate clearance in Huntington's disease.
Neurobiol Dis 2010 Dec;40(3):656-62.
- Karlsborg M, Korbo L, Regeur L & Glad A.
Duodopapumpebehandling til patienter med fremskreden Parkinsons
sygdom.Ugeskr Laeger 2010 Jun 7;172(23):1745.
- Lesca G, Boutry-Kryza N, de TB, Milh M, Steschenko D,
Lemesle-Martin M, Maillard L, Foletti G, Rudolf G, Nielsen JE,
Rogvi-Hansen B, Erdal J, Mancini J, Thauvin-Robinet C, M'Rrabet A,
Ville D, Szepetowski P, Raffo E, Hirsch E, Ryvlin P, Calender A
& Genton P. Novel mutations in EPM2A and NHLRC1 widen the
spectrum of Lafora disease. Epilepsia 2010 Sep;51(9):1691-8.
- Lopez OL, Schwam E, Cummings J, Gauthier S, Jones R, Wilkinson
D, Waldemar G, Zhang R & Schindler R. Predicting cognitive
decline in Alzheimer's disease: an integrated analysis. Alzheimers
Dement 2010 Nov;6(6):431-9.
- Lotjonen JM, Wolz R, Koikkalainen JR, Thurfjell L, Waldemar G,
Soininen H & Rueckert D. Fast and robust multi-atlas
segmentation of brain magnetic resonance images. Neuroimage 2010
Feb 1;49(3):2352-65.
- Madureira S, Verdelho A, Moleiro C, Ferro JM, Erkinjuntti T,
Jokinen H, Pantoni L, Fazekas F, Van der FW, Visser M, Waldemar G,
Wallin A, Hennerici M & Inzitari D. Neuropsychological
predictors of dementia in a three-year follow-up period: data from
the LADIS study. Dement Geriatr Cogn Disord 2010;29(4):325-34.
- Marner L, Knudsen GM, Madsen K, Holm S, Baare W &
Hasselbalch SG. Brain imaging of serotonin 4 receptors in humans
with [11C]SB207145-PET. Neuroimage 2010 Apr 15;50(3):855-61.
- Nielsen TR, Bruhn P, Nielsen JE & Hjermind LE. Behavioral
variant of frontotemporal dementia mimicking Huntington's disease.
Int Psychogeriatr 2010 Jun;22(4):674-7.
- Nielsen TR, Vogel A, Riepe MW, de MA, Rodriguez G, Nobili F,
Gade A & Waldemar G. Assessment of dementia in ethnic minority
patients in Europe: a European Alzheimer's Disease Consortium
survey. Int Psychogeriatr 2010 Jul 6;1-10.
- Petri AL, Simonsen AH, Hogdall E, Christensen IJ, Kjaer SK, Yip
C, Risum S, Pedersen AT, Hartwell D, Fung ET & Hogdall C.
Comparison of proteomic biomarker panels in urine and serum for
ovarian cancer diagnosis. Proteomics Clin Appl 2010
Mar;4(3):304-14.
- Phung TK, Waltoft BL, Laursen TM, Settnes A, Kessing LV,
Mortensen PB & Waldemar G. Hysterectomy, oophorectomy and risk
of dementia: a nationwide historical cohort study. Dement Geriatr
Cogn Disord 2010;30(1):43-50.
- Phung TK, Waltoft BL, Kessing LV, Mortensen PB & Waldemar
G. Time trend in diagnosing dementia in secondary care. Dement
Geriatr Cogn Disord 2010;29(2):146-53.
- Schmidt R, Ropele S, Ferro J, Madureira S, Verdelho A, Petrovic
K, Gouw A, van der Flier WM, Enzinger C, Pantoni L, Inzitari D,
Erkinjuntti T, Scheltens P, Wahlund LO, Waldemar G, Rostrup E,
Wallin A, Barkhof F & Fazekas F. Diffusion-weighted imaging and
cognition in the leukoariosis and disability in the elderly study.
Stroke 2010 May;41(5):e402-e408.
- Schultz K, Nilsson K, Nielsen JE, Lindquist SG, Hjermind LE,
Andersen BB, Wallin A, Nilsson C & Petersen A. Transthyretin as
a potential CSF biomarker for Alzheimer's disease and dementia with
Lewy bodies: effects of treatment with cholinesterase inhibitors.
Eur J Neurol 2010 Mar;17(3):456-60.
- Simonsen AH, Bech S, Laursen I, Salvesen L, Winge K, Waldemar
G, Werdelin L, Nielsen JE, McGuire JN & Hjermind LE. Proteomic
investigations of the ventriculo-lumbar gradient in human CSF. J
Neurosci Methods 2010 Aug 30;191(2):244-8.
- Svenstrup K, Giraud G, Boespflug-Tanguy O, Danielsen ER,
Thomsen C, Rasmussen K, Law I, Vogel A, Stokholm J, Crone C,
Hjermind LE & Nielsen JE. Hereditary spastic paraplegia caused
by the PLP1 'rumpshaker mutation'. J Neurol Neurosurg Psychiatry
2010 Jun;81(6):666-72.
- Teodorczuk A, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T,
Wallin A, Wahlund LO, Scheltens P, Waldemar G, Schrotter G, Ferro
JM, Chabriat H, Bazner H, Visser M, Inzitari D & O'Brien JT.
Relationship between baseline white-matter changes and development
of late-life depressive symptoms: 3-year results from the LADIS
study. Psychol Med 2010 Apr;40(4):603-10.
- Urwin H, Authier A, Nielsen JE, Metcalf D, Powell C, Froud K,
Malcolm DS, Holm I, Johannsen P, Brown J, Fisher EM, van der ZJ,
Bruyland M, Van BC, Collinge J, Brandner S, Futter C & Isaacs
AM. Disruption of endocytic trafficking in frontotemporal dementia
with CHMP2B mutations. Hum Mol Genet 2010 Jun 1;19(11):2228-38.
- Urwin H, Josephs KA, Rohrer JD, Mackenzie IR, Neumann M,
Authier A, Seelaar H, Van Swieten JC, Brown JM, Johannsen P,
Nielsen JE, Holm IE, Dickson DW, Rademakers R, Graff-Radford NR,
Parisi JE, Petersen RC, Hatanpaa KJ, White CL, III, Weiner MF,
Geser F, Van D, V, Trojanowski JQ, Miller BL, Seeley WW, van der
ZJ, Kumar-Singh S, Engelborghs S, De Deyn PP, Van BC, Bigio EH,
Deng HX, Halliday GM, Kril JJ, Munoz DG, Mann DM, Pickering-Brown
SM, Doodeman V, Adamson G, Ghazi-Noori S, Fisher EM, Holton JL,
Revesz T, Rossor MN, Collinge J, Mead S & Isaacs AM. FUS
pathology defines the majority of tau- and TDP-43-negative
frontotemporal lobar degeneration. Acta Neuropathol 2010
Jul;120(1):33-41.
- Vandenberghe R, Van LK, Ivanoiu A, Salmon E, Bastin C, Triau E,
Hasselbalch S, Law I, Andersen A, Korner A, Minthon L, Garraux G,
Nelissen N, Bormans G, Buckley C, Owenius R, Thurfjell L, Farrar G
& Brooks DJ. 18F-flutemetamol amyloid imaging in Alzheimer
disease and mild cognitive impairment: a phase 2 trial. Ann Neurol
2010 Sep;68(3):319-29.
- Verdelho A, Madureira S, Moleiro C, Ferro JM, Santos CO,
Erkinjuntti T, Pantoni L, Fazekas F, Visser M, Waldemar G, Wallin
A, Hennerici M & Inzitari D. White matter changes and diabetes
predict cognitive decline in the elderly: the LADIS study.
Neurology 2010 Jul 13;75(2):160-7.
- Vogel A, Waldorff FB & Waldemar G. Impaired awareness of
deficits and neuropsychiatric symptoms in early Alzheimer's
disease: the Danish Alzheimer Intervention Study (DAISY). J
Neuropsychiatry Clin Neurosci 2010;22(1):93-9.